1.7(top 50%)
impact factor
1.2K(top 20%)
6.9K(top 20%)
32(top 20%)
1.8(top 50%)
extended IF
all documents
doc citations
47(top 20%)

Top Articles

1Global Epidemiology of Chronic Liver DiseaseClinical Liver Disease2021247
2Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B GuidanceClinical Liver Disease2018187
3Nonalcoholic Fatty Liver Disease and Recent Guideline UpdatesClinical Liver Disease2021108
4Nonalcoholic fatty liver disease: Definitions, risk factors, and workupClinical Liver Disease201295
5Recent trends in the epidemiology of alcoholic liver diseaseClinical Liver Disease201380
6Standard liver testsClinical Liver Disease201669
7The epidemiology of nonalcoholic steatohepatitisClinical Liver Disease201864
8Bile Acid Biology, Pathophysiology, and TherapeuticsClinical Liver Disease202061
9Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Liver Disease201960
10Congestive hepatopathyClinical Liver Disease201659
11Patterns of necrosis in liver diseaseClinical Liver Disease201753
12Risk factors for hepatocellular carcinomaClinical Liver Disease201252
13Epidemiology of Alcohol Use and Alcoholic Liver DiseaseClinical Liver Disease201952
14Interrelationship Between Coronavirus Infection and Liver DiseaseClinical Liver Disease202052
15Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisClinical Liver Disease201851
16Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesClinical Liver Disease201949
17Histopathology of alcoholic liver diseaseClinical Liver Disease201347
18Reactivation of Hepatitis B Virus: A Review of Clinical GuidelinesClinical Liver Disease202047
19Epidemiology of Hepatitis B Virus Infection in the United StatesClinical Liver Disease201844
20Ectopic varicesClinical Liver Disease201239
21Role of special stains in diagnostic liver pathologyClinical Liver Disease201339
22The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease OutcomesClinical Liver Disease201839
23Pain management in patients with cirrhosisClinical Liver Disease201839
24Pyogenic liver abscessClinical Liver Disease201538
25Biomarkers for monitoring alcohol useClinical Liver Disease201638
26Epidemiology of Pediatric Nonalcoholic Fatty Liver DiseaseClinical Liver Disease202138
27Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkersClinical Liver Disease201237
28The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesClinical Liver Disease201837
29Chronic Liver Disease and COVID‐19: Alcohol Use Disorder/Alcohol‐Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated CirrhosisClinical Liver Disease202037
30Association of Sarcopenia and NAFLD: An OverviewClinical Liver Disease202036
31Preeclampsia‐induced Liver Dysfunction, HELLP syndrome, and acute fatty liver of pregnancyClinical Liver Disease201435
32Microscopic anatomy of the liverClinical Liver Disease201334
33Silymarin in the treatment of liver diseases: What is the clinical evidence?Clinical Liver Disease201634
34What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?Clinical Liver Disease201934
35A brief history of the treatment of viral hepatitis C†Clinical Liver Disease201232
36Model for end‐stage liver disease exception points for treatment‐responsive hepatocellular carcinomaClinical Liver Disease201631
37Cannabinoids in liver diseasesClinical Liver Disease201631
38An update on the pharmacological treatment of nonalcoholic fatty liver disease: Beyond lifestyle modificationsClinical Liver Disease201831
39AASLD/IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis CClinical Liver Disease201831
40SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascitesClinical Liver Disease201831
41Nonalcoholic Fatty Liver Disease and Cardiovascular DiseaseClinical Liver Disease202131
42Normal liver anatomyClinical Liver Disease201330
43Telemedicine and Telehepatology During the COVID‐19 PandemicClinical Liver Disease202030
44Bacterial infections in cirrhosis: A growing problem with significant implicationsClinical Liver Disease201329
45Elastography to assess the stage of liver fibrosis in children: Concepts, opportunities, and challengesClinical Liver Disease201729
46Epidemiology of Hepatitis CClinical Liver Disease201829
47Treatment for Advanced Hepatocellular Carcinoma: Current Standard and the FutureClinical Liver Disease201929
48SARS‐CoV‐2 and the Liver: Considerations in Hepatitis B and Hepatitis C InfectionsClinical Liver Disease202029
49Altered Microbiota in Cirrhosis and Its Relationship to the Development of InfectionClinical Liver Disease201928
50Primary Sclerosing Cholangitis: Epidemiology, Genetics, Diagnosis, and Current ManagementClinical Liver Disease202028